Palvella TherapeuticsPVLA
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 41 institutions reported holding Palvella Therapeutics Inc. (PVLA) in their 13F filings, up 8 from Q4 2024. 15 opened new positions and 7 sold out. The largest holders were Montanova Capital, LLC ($20.0M), BVF Inc. ($19.5M) and Frazier Life Sciences Management, L.P. ($19.3M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Palvella Therapeutics Inc.
- CUSIP
- 697947109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $29.6M |
| Exits | 7 | $2.4M |
All 13F filers, Q4 2024 → Q1 2025: 1,433,375 shares bought and 343,091 shares sold, net +1,090,284 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 41 holders
| Montanova Capital, LLC | 0.81% | No change | 714,463 | $20.0M |
| BVF Inc. | 0.79% | No change | 696,555 | $19.5M |
| Frazier Life Sciences Management, L.P. | 0.88% | Add +5.5% | 690,012 | $19.3M |
| Samsara Biocapital, LLC | 3.39% | No change | 679,486 | $19.0M |
| Adams Street Partners LLC | 10.15% | No change | 409,666 | $11.5M |
| Millennium Management | 0.01% | New | 269,837 | $7.6M |
| Nantahala Capital Management, LLC | 0.58% | No change | 250,062 | $7.0M |
| Woodline Partners LP | 0.04% | New | 194,167 | $5.4M |
| Opaleye Management Inc. | 1.10% | New | 172,357 | $4.8M |
| Blue Owl Capital Holdings LP | 1.27% | Reduce -43.9% | 140,259 | $3.9M |
| Vanguard Group Inc. | 0.00% | Add +1120.5% | 138,433 | $3.9M |
| Susquehanna International Group, LLP | 0.01% | New | 114,388 | $3.2M |
| BlackRock, Inc. | 0.00% | Add +756.1% | 110,758 | $3.1M |
| Geode Capital Management, LLC | 0.00% | Add +560.1% | 94,199 | $2.6M |
| Royce & Associates LP | 0.02% | New | 71,514 | $2.0M |
| AWM Investment Company, Inc. | 0.27% | New | 69,416 | $1.9M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.03% | New | 48,664 | $1.4M |
| DAFNA Capital Management LLC | 0.35% | Reduce -39.3% | 43,348 | $1.2M |
| Marshall Wace, LLP | 0.00% | New | 30,345 | $849K |
| Strid Group, LLC | 0.13% | New | 29,219 | $818K |
| Cresset Asset Management, LLC | 0.00% | No change | 20,911 | $585K |
| Goldman Sachs Group Inc. | 0.00% | New | 19,053 | $533K |
| Toronto Dominion Bank | 0.00% | Add +42.9% | 18,872 | $528K |
| Northern Trust Corp. | 0.00% | New | 16,635 | $466K |
| Renaissance Technologies | 0.00% | Reduce -28.6% | 15,258 | $427K |
| Deltec Asset Management LLC | 0.08% | No change | 12,500 | $350K |
| State Street Corp. | 0.00% | New | 12,062 | $338K |
| UBS Group AG | 0.00% | Add +4877.2% | 10,054 | $281K |
| Morgan Stanley | 0.00% | Add +10786.8% | 9,907 | $277K |
| Balyasny Asset Management L.P. | 0.00% | New | 8,176 | $229K |
| Bank of America Corp. | 0.00% | Add +63308.3% | 7,609 | $213K |
| Spire Wealth Management | 0.00% | New | 2,516 | $70K |
| Citigroup Inc. | 0.00% | Add +102.7% | 2,246 | $63K |
| Group One Trading LLC | 0.00% | No change | 312 | $9K |
| Barclays PLC | 0.00% | No change | 63 | $2K |
| Wells Fargo & Company | 0.00% | No change | 50 | $1K |
| Truvestments Capital LLC | 0.00% | No change | 14 | $392 |
| Allworth Financial LP | 0.00% | No change | 5 | $128 |
| JPMorgan Chase & Co. | 0.00% | Reduce -88.5% | 3 | $84 |
| Jones Financial Companies LLLP | 0.00% | No change | 3 | $84 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is PVLA's weight in each manager's 13F, not the share of Palvella Therapeutics Inc. the manager owns.